Apple Inc

NASDAQ: AAPL
$224.97
+$3.28 (+1.5%)
Real Time Data Delayed 15 Min.

AAPL Articles

That's a lot of poison and nutraceuticals.
This Yale lawyer says current antitrust laws are enabling Apple, not reining it in.
The top analyst upgrades, downgrades and initiations seen on Friday include Apple, Caterpillar, Costco, GW Pharmaceuticals, NXP Semiconductors, Southwest Airlines, Teva Pharmaceutical, Ulta Beauty...
Merrill Lynch has a cool graphic.
From a note to clients that landed in my inbox Friday: Apple is set to announce new products on September 12 in Cupertino, CA. In this…
Continuing the Gene Munster tradition of survey-based, middle-of-the-road analysis. 
From 9to5Mac: ‘iPhone Xs Max’ likely name for 6.5-inch OLED flagship, sources say.
From a Counterpoint Research report dated last Wednesday, released today.
I agree with AppleInsider, but something tells me they've been trolled.
Streaming video and music could become a $22 billion business by 2025, says Katy Huberty, roughly the size of Netflix plus Spotify. From a note to…
Cue is not the only SVP with too much on his plate. 
Sacconaghi sticks with a price target that says Apple at $228 is headed for a fall.
The top analyst upgrades, downgrades and initiations seen on Wednesday included Amazon, Apple, BP, CSX, General Electric, Humana, Myriad Genetics, Mondelez, UnitedHealth and Vodafone.
Having read the rationale, I still can't make sense of Kvaal's call. 
It's not like Walkley to let Apple's stock price overtake his price target.